Medicare Enrolled

Dr. Helder De Paiva, M.D.

Optician · Los Angeles, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
5901 W OLYMPIC BLVD, Los Angeles, CA 90036
3102052595
In practice since 2006 (19 years)
NPI: 1174610273 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. De Paiva from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. De Paiva? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. De Paiva

Dr. Helder De Paiva is an optician specialist in Los Angeles, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. De Paiva performed 4,409 Medicare services across 1,350 unique beneficiaries.

Between the years covered by Open Payments, Dr. De Paiva received a total of $6,818 from 46 pharmaceutical and/or device companies across 181 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. De Paiva is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 20% volume in CA $6,818 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,409
Medicare services
Top 20% in CA for optician
1,350
Unique beneficiaries
$94
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~232 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
2,603 $67 $400
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
996 $101 $600
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
426 $148 $1,100
Dialysis services for patients 20 or older
Dialysis treatment provided to patients aged 20 years or older, involving four or more physician visits per month.
169 $297 $1,550
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
152 $106 $598
Critical care, first 30-74 min
Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient.
63 $181 $1,500
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,818
Total received (2018-2024)
Avg $974/year across 7 years
Top 19% in CA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
181
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,337 (78.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,482 (21.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,347
2023
$1,337
2022
$1,198
2021
$303
2020
$339
2019
$287
2018
$2,007

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Ardelyx, Inc.
$383
Amgen Inc.
$205
AstraZeneca Pharmaceuticals LP
$201
Novartis Pharmaceuticals Corporation
$100
Mallinckrodt Hospital Products Inc.
$88
Bayer Healthcare Pharmaceuticals Inc.
$86
Boehringer Ingelheim Pharmaceuticals, Inc.
$59
AKEBIA THERAPEUTICS INC
$54
Outset Medical Inc
$48
Aurinia Pharma U.S., Inc.
$39
GlaxoSmithKline, LLC.
$34
Lilly USA, LLC
$29
Alnylam Pharmaceuticals Inc.
$22
Top 3 companies account for 58.6% of 2024 payments
All-time payments by company (2018-2024) ›
Otsuka America Pharmaceutical, Inc.
$1,247
AstraZeneca Pharmaceuticals LP
$687
Amgen Inc.
$464
GastroKlenz, Inc. DBA CloudCath
$400
Ardelyx, Inc.
$383
Allergan Inc.
$354
Outset Medical Inc
$309
Mallinckrodt Hospital Products Inc.
$303
Horizon Therapeutics plc
$280
GlaxoSmithKline, LLC.
$224
Avanir Pharmaceuticals, Inc.
$197
Bayer Healthcare Pharmaceuticals Inc.
$163
ANI Pharmaceuticals, Inc.
$150
Synergy Pharmaceuticals Inc
$125
Boehringer Ingelheim Pharmaceuticals, Inc.
$124
Takeda Pharmaceuticals U.S.A., Inc.
$110
Aurinia Pharma U.S., Inc.
$107
OPKO Pharmaceuticals, LLC
$101
Novartis Pharmaceuticals Corporation
$100
Regeneron Healthcare Solutions, Inc.
$89
Alkermes, Inc.
$85
AKEBIA THERAPEUTICS INC
$75
kaleo, Inc.
$74
Alexion Pharmaceuticals, Inc.
$61
Calliditas Therapeutics US Inc.
$50
ALK-Abello, Inc
$45
Novo Nordisk Inc
$43
Sunovion Pharmaceuticals Inc.
$39
Horizon Pharma plc
$36
Grifols USA, LLC
$35
Kyowa Kirin, Inc.
$30
Lilly USA, LLC
$29
Mallinckrodt Enterprises LLC
$28
Ironwood Pharmaceuticals, Inc
$27
OptiNose US, Inc.
$25
Galderma Laboratories, L.P.
$23
Alnylam Pharmaceuticals Inc.
$22
Bayer HealthCare Pharmaceuticals Inc.
$22
MITSUBISHI TANABE PHARMA AMERICA, INC.
$21
BAXTER HEALTHCARE
$20
Incyte Corporation
$20
Keryx Biopharmaceuticals, Inc.
$20
Janssen Pharmaceuticals, Inc
$19
Shire North American Group Inc
$19
Genentech USA, Inc.
$18
Fresenius USA Marketing, Inc.
$14
Top 3 companies account for 35.2% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMVUTTRA · APTIOM · AUVI-Q · AVYCAZ · Aimovig · Auryxia · BENLYSTA · DALVANCE · DUPIXENT · FARXIGA · IBSRELA · INVOKANA · JARDIANCE · JESDUVROQ · JYNARQUE · KRYSTEXXA · Kerendia · LOKELMA · LUPKYNIS · Linzess · NATPARA · NUEDEXTA · OPZELURA · Odactra · PURIFIED CORTROPHIN GEL · Parsabiv · RADICAVA · RAYALDEE · RYBELSUS · Rayaldee · Rayaldee (old) · Renal - PD · Rybelsus · SAMSCA · TAKHZYRO · TARPEYO · TAVNEOS · TEZSPIRE · Trulance · UTIBRON NEOHALER · Vafseo · Velphoro · Vivitrol 380 mg · XPHOZAH 30 MG · Xembify · Xhance · Xofluza
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (78%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an optician specialist in Los Angeles?
Compare opticians in the Los Angeles area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
1,559
Per 100K population
15.8
County median income
$87,760
Nearest hospital
DOCS SURGICAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. De Paiva is a mixed practice specialist, with above-average Medicare volume (top 20% in CA), with low-engagement industry engagement in the top 19% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. De Paiva experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. De Paiva performed 2,603 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. De Paiva receive payments from pharmaceutical companies?
Yes. Dr. De Paiva received a total of $6,818 from 46 companies across 181 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. De Paiva's costs compare to other opticians in Los Angeles?
Dr. De Paiva's average Medicare payment per service is $94. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. De Paiva) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →